Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1981-1-29
pubmed:abstractText
18 children with cystic fibrosis and mucoid pseudomonas lung infection were treated with courses either of gentamicin plus carbenicillin, or tobramycin plus carbenicillin, with 2 children each receiving two courses. 10 courses of gentamicin at a dose of 9 mg/kg per day plus carbenicillin at 800 mg/kg per day, and 10 courses of tobramycin at 9 mg/kg per day plus carbenicillin at 800 mg/kg per day were given. There was clinical and x-ray improvement in both groups of children, but there was no difference between the therapeutic benefit of either regimen. Pseudomonas aeruginosa was not cultured at the end of treatment after 15 of the 20 courses, but it returned in all but one patient within 3 months. Neither ototoxicity nor renal damage with these high doses of aminoglycoside was detected. P. aeruginosa had not been eliminated when 9 of these patients earlier had received courses of gentamicin in a dose of 6 mg/kg per day plus carbenicillin at 800 mg/kg per day. The results show that P. aeruginosa can successfully be eliminated or suppressed with high-dose aminoglycoside plus carbenicillin, but such elimination is usually short lived.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7436516-15822331, http://linkedlifedata.com/resource/pubmed/commentcorrection/7436516-401521, http://linkedlifedata.com/resource/pubmed/commentcorrection/7436516-4153350, http://linkedlifedata.com/resource/pubmed/commentcorrection/7436516-4170754, http://linkedlifedata.com/resource/pubmed/commentcorrection/7436516-4199274, http://linkedlifedata.com/resource/pubmed/commentcorrection/7436516-4209057, http://linkedlifedata.com/resource/pubmed/commentcorrection/7436516-4213330, http://linkedlifedata.com/resource/pubmed/commentcorrection/7436516-4217466, http://linkedlifedata.com/resource/pubmed/commentcorrection/7436516-4630477, http://linkedlifedata.com/resource/pubmed/commentcorrection/7436516-4992840, http://linkedlifedata.com/resource/pubmed/commentcorrection/7436516-5000612, http://linkedlifedata.com/resource/pubmed/commentcorrection/7436516-5018658, http://linkedlifedata.com/resource/pubmed/commentcorrection/7436516-779549, http://linkedlifedata.com/resource/pubmed/commentcorrection/7436516-821911
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1468-2044
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
55
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
604-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1980
pubmed:articleTitle
Gentamicin and tobramycin compared in the treatment of mucoid pseudomonas lung infections in cystic fibrosis.
pubmed:publicationType
Journal Article, Comparative Study